跳至主要内容
临床试验/NCT06440096
NCT06440096已完成不适用

Harran University Hospital Department of Physical Medicine and Rehabilitation

Veysel Delen, MD1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2023年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
48
试验地点
1
主要终点
Hemogram-derived inflammation indexes

研究概览

简要总结

Some indicators generated from hemogram such as neutrophil/lymphocyte (NLR) have been suggested as biomarkers of systemic inflammation. Type I Modic changes (MCs) have inflammatory nature histologically and are more painful clinically than type II MCs. Therefore, we hypothesized that patients with type I MCs may have increased inflammatory biomarkers and low back pain than those with type II MCs. The aim of this study was to test this hypothesis.

详细描述

Patients and Methods: A total of 48 patients with MCs (type I/type II=24/24) were included in this study. Their demographic, clinical and hematologic characteristics were recorded. A 10 cm Visual Analog Scale (VAS) was used to detect low back pain intensity. Systemic inflammatory biomarkers including NLR, monocyte/lymphocyte (MLR), platelet/lymphocyte (PLR), neutrophil/lymphocyte*platelet (NLPR), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI) were derived from whole blood cell count.

Keywords: Neutrophil-to-lymphocyte ratio, inflammation, Modic changes, back pain.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria were male or female with type I or type II MCs, aged ≥18 and ≤64 years old, and accepted informed consent to participation.

排除标准

  • type III MCs and a combination of MCs' types were excluded. In addition, acute low back pain, spinal deformities, inflammatory diseases, cancers, heart diseases, stroke, lactation, pregnancy, psychiatric disorders, and extreme obesity (BMI≥40 kg/m²) were also excluded.

结局指标

主要结局

Hemogram-derived inflammation indexes

时间窗: 10 minutes

blood-based

次要结局

未报告次要终点

研究者

发起方
Veysel Delen, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Veysel Delen, MD

Harran University Hospital

Sanliurfa Mehmet Akif Inan Education and Research Hospital

研究点 (1)

Loading locations...

相似试验